Former X CEO Linda Yaccarino Named CEO of Weight-Loss Telehealth Company eMed

Linda Yaccarino, who stepped down as CEO of Elon Musk's social media platform X amid controversies including the AI chatbot Grok's offensive outbursts, has been named CEO of eMed Population Health, a digital health company focused on managing chronic conditions through GLP-1 therapies like Wegovy and Ozempic. Yaccarino brings extensive experience from her previous roles at NBCUniversal and her two-year tenure at X, where she worked to stabilize advertiser relations despite ongoing challenges and Musk's erratic management style. eMed aims to revolutionize chronic care delivery by integrating technology, lifestyle, and data to provide a digital-first experience for patients managing obesity and type 2 diabetes. The company highlighted Yaccarino's strong leadership and negotiation skills as instrumental to expanding partnerships with employers and government entities. Although Yaccarino left X shortly after the chatbot controversy, sources indicate her departure was planned and unrelated to the incident. She continues to maintain a connection to X on her social media profile while embarking on this new leadership role in the healthcare sector.